Navigation Links
Byetta Pancreatic Cancer Lawsuit News: Bernstein Liebhard LLP Comments on BMJ Investigation Finding Incretin Mimetic Risks Were Downplayed
Date:6/20/2013

New York, New York (PRWEB) June 20, 2013

Byetta pancreatic cancer lawsuit filings continue to mount in courts around the country, Bernstein Liebhard LLP notes that a new investigation by the British Medical Journal (BMJ) has concluded that the pancreatic risks associated with incretin mimetics like Byetta may have been downplayed by the drugs’ manufacturers. According to a report from MedPageToday.com, the BMJ investigation consisted of a review of regulatory documents that discovered unpublished data pointing to “unwanted proliferative or inflammatory pancreatic effects” associated with incretin mimetics. The authors of the report also faulted the U.S. Food & Drug Administration (FDA) and European regulators for failing to aggressively address these concerns.*

“This report just confirms that links between Byetta and pancreatic cancer, as well as pancreatitis, need further review,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Byetta pancreatic cancer lawsuit evaluations to patients who took this drug and were later diagnosed with the disease. Bernstein Liebhard LLP is also investigating claims related to Byetta pancreatitis and thyroid cancer.

Byetta Pancreatic Cancer Lawsuits

Court documents indicate that dozens of Byetta lawsuits have been filed by plaintiffs who suffered pancreatitis and pancreatic cancer, allegedly due to their use of the drug. The U.S. Judicial Panel on Multidistrict Litigation (JPML) will meet on July 25th to hear Oral Arguments regarding the proposed consolidation of all federally-filed personal injury lawsuits involving Byetta and other incretin mimetics. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, JPML)

Concern’s
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rottenstein Law Group LLP Comments on Drugmakers’ Cooperation With Safety Review of Byetta, Januvia, Victoza
2. Diabetes Drug Byetta Caused Arkansas Man’s Pancreatic Cancer and Resulting Injuries, Alleges Lawsuit Filed by Parker Waichman LLP and Co-Counsel
3. Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports
4. DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court
5. Byetta Lawsuit News: Woman Alleges Her Thyroid Cancer Is Linked to Byetta Use, Rottenstein Law Group LLP Reports
6. DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
7. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
8. DrugRisk Announces Launch of Byetta Cancer Resource Center
9. Byetta Pancreatic Cancer Allegation Lawsuits Offered through Resource4thePeople
10. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
11. Pancreatic Cancer Survivor and Author Bob Brown Releases Highly Anticipated New Book "Ride of My Life"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015 According to a recently published ... repair market will continue to dominate the European soft ... due to increasing numbers of ventral hernias, and the ... “The significantly large market share represented by ventral hernia ... We’re seeing a growing use of expensive biologics,” explains ...
(Date:3/30/2015)... This report studies the global tumor ablation ... 2019. , Based on the type of technology, ... four major segments, namely radio-frequency, microwave, cryoablation and ... laser ablation) segments. Moreover, based on type of ... into three segments, namely, interventional radiology, surgery and ...
(Date:3/30/2015)... 2015 On March 19th, 2015, in ... of the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction ... ministers and bishops as well as other civic leaders ... at the luncheon, including retired Detroit Lions wide receiver ... and two survivors of their own personal battles with ...
(Date:3/30/2015)... Pa. (PRWEB) March 30, 2015 ... the Halal certification for all current Epax® Ultra ... facility in Ålesund, Norway. The certification ensures the ... comply with the Islamic religious regulations for Halal. ... step in FMC’s efforts to further advance its ...
(Date:3/30/2015)... GenSight ®, provider of an Enterprise Portfolio ... The Forrester Wave™: Strategic Planning For The [Business Technology] ... positions GenSight as a leader and gave the company ... the analytics, corporate strategy, assessment, direction and life cycle ... the Leaders category. , According to the report: ...
Breaking Medicine News(10 mins):Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3
... that ravaged medieval Europe has a weakness that could help ... a study published on Thursday. ,A bacterium known ... Death spread when people are bitten by an infected flea, ... coughing or sneezing. ,There are periodic natural outbreaks ...
... comes to some of today’s health issues, 100 percent ... related to certain diseases – concludes// a study by ... ability to reduce risk compared to their whole fruit/vegetable ... conducted the literature review. The researchers analyzed a variety ...
... heavily on alternative therapists who mistreat their patients sexually ... therapists said to exist in Britain and there are ... On the other hand, completely qualified medical practitioners who ... rules and guidelines regarding their relationship with their patients. ...
... have a longer average lifespan than most of the men ... where it is usually reported// that people live longer on ... social policy study published on Wednesday, healthy Israeli men live ... than men, average lifespan of 82.4 years, on par with ...
... A US government funded study finds that CT scans used ... to be replaced by MRI scans which are better in ... should now be passed to magnetic resonance imaging,” wrote Dr. ... in Australia in a note accompanying the study report. ...
... presentation into Japanese for an American client who wants to ... not many can undertake. //And all this from Chennai too! ... proving that it is possible. Specialising in providing software services ... on the dot and raking in millions of dollars in ...
Cached Medicine News:Health News:Scientists Find Potential Weakness In Plague Germ 2Health News:Benefits of Fruit and Vegetable Juices 2Health News:Cashing in on IT for Healthcare 2
(Date:3/30/2015)... OF PRUSSIA, Pa. , March 30, 2015 ... the European Medicines Agency (EMA) has started the ... Application (MAA) for its long-acting fusion protein linking ... Upon European Commission approval, rIX-FP will provide hemophilia ... well as the European Economic Area (EEA) countries, ...
(Date:3/30/2015)... , March 30, 2015  BioPharmX Corporation (OTCQB: ... development of novel drug delivery products to address ... today announced the appointment of Stephen Morlock ... veteran, to its board of directors.  Mr. Morlock,s ... to expand its national roll-out of Violet iodine, ...
(Date:3/30/2015)... 30, 2015 Beta-O2 ... as the company,s new chief executive officer. Dr. ... leading early stage Israeli venture capital firm. He is ... and vascular surgery.        (Logo: http://photos.prnewswire.com/prnh/20140910/705638) ... Sherpa Innoventures is Beta-O2,s newest investor, having participated in ...
Breaking Medicine Technology:European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3
... 5, 2011 Jennerex, Inc., a private clinical-stage ... of first-in-class targeted oncolytic products for cancer, and ... specialized in the development of immunotherapeutic products, today ... 2 clinical studies of JX-594 were presented in ...
... Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced preliminary ... The Company announced the preliminary metrics in advance of the ... Executive Officer of Questcor, will present on Tuesday, April 5, ... web cast of the presentation during or after the event, ...
Cached Medicine Technology:Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 2Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 3Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 4Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 2Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 3Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 4Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 6Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 7Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 8
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
Plastic Economical Single use. Non-Sterile....
Medicine Products: